Pharmaceutical Interventions for ASD

Saturday, May 14, 2016: 2:40 PM-3:30 PM
Room 308 (Baltimore Convention Center)
2:40 PM
The Role of Precompetitive Consortia, Data Sharing and Regulatory Science in Catalyzing Innovation for Autism Spectrum Disorders
D. T. Stephenson B. Abrahams K. Romero J. Larkindale J. McPartland L. Fitzgerald H. Mayer J. E. Spiro M. T. Pletcher W. Spooren
3:04 PM
A Double-Blind, Placebo-Controlled Trial of Memantine Vs. Placebo in Children with Autism Targeting Neurocognitive Outcomes
L. Soorya S. Youngkin S. J. Lee J. W. Lee A. Mischel D. Graber D. Grodberg H. T. Rieger D. Zaghloul E. Anagnostou
3:16 PM
The Effects of a Novel Vasopressin V1a Antagonist in Combination with Others' Gaze Behaviors on Attention to Others' Heads in Adults with ASD
C. Foster M. del Valle Rubido J. McCracken E. Hollander L. Scahill L. Boak O. Khwaja F. Bolognani P. Fontoura D. Umbricht S. S. Jeste E. S. Kim R. J. Jou C. A. Wall F. Shic